Alnylam Pharmaceuticals, Inc. (ALNY)

330.78 +14.69 (+4.65%) USD  |  NASDAQ  |  Mar 31, 16:00
333.50 +2.72 (+0.82%) After-Hours: 19:46
More

Alnylam Pharmaceuticals Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade